Tarsus Pharmaceuticals (TARS) EPS (Basic) (2019 - 2026)
Tarsus Pharmaceuticals' (TARS) quarterly EPS (Basic) came in at -$0.16 in Q1 2026, up 74.66% year-on-year from -$0.09 in Q1 2025, and down 7.99% quarter-over-quarter from -$0.15 in Q4 2025.
Tarsus Pharmaceuticals (TARS) EPS (Basic) (2019 - 2026) Analysis & Trends
Tarsus Pharmaceuticals' EPS (Basic) history runs 8 years deep, the most recent figure standing at -$0.16 for Q1 2026.
- On a quarterly basis, EPS (Basic) rose 74.66% year-over-year to -$0.16 in Q1 2026; TTM through Mar 2026 was -$3.48, a 33.05% decrease from a year earlier, with the FY2025 full-year figure at -$1.59, up 48.27% from the prior year.
- EPS (Basic) fell to -$0.16 in Q1 2026 per TARS's latest filing, from -$0.15 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.15 in Q4 2025 and bottomed at -$2.92 in Q2 2025.
- The 5-year median for EPS (Basic) is -$0.83 (2024), against an average of -$0.86.
- Across the five-year window, EPS (Basic) slumped 420.95% in 2023 and jumped 75.73% in 2025, its largest moves.
- Year by year, EPS (Basic) stood at -$0.53 in 2022, then plunged by 171.54% to -$1.45 in 2023, then jumped by 57.43% to -$0.62 in 2024, then soared by 75.73% to -$0.15 in 2025, then dropped by 7.99% to -$0.16 in 2026.
- Per Business Quant, the three latest TARS EPS (Basic) figures stand at -$0.16 (Q1 2026), -$0.15 (Q4 2025), and -$0.3 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Tarsus Pharmaceuticals | 2.52 Bn | 2.41 Bn | 152.66 Mn | -0.16 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.16 |
| Dec 31, 2025 | -0.15 |
| Sep 30, 2025 | -0.30 |
| Jun 30, 2025 | -2.92 |
| Mar 31, 2025 | -0.64 |
| Dec 31, 2024 | -0.62 |
| Sep 30, 2024 | -0.61 |
| Jun 30, 2024 | -0.83 |
| Mar 31, 2024 | -1.01 |
| Dec 31, 2023 | -1.45 |
| Sep 30, 2023 | -1.27 |
| Jun 30, 2023 | -1.17 |
| Mar 31, 2023 | -0.87 |
| Dec 31, 2022 | -0.53 |
| Sep 30, 2022 | -0.84 |
| Jun 30, 2022 | -0.22 |
| Mar 31, 2022 | -0.96 |
| Dec 31, 2021 | -0.71 |
| Sep 30, 2021 | -0.74 |
| Jun 30, 2021 | 0.35 |